Friday, 16 May 2014

Conference on Biowaivers

OMICS Group International contributes to the scientific community through its Open Access Initiative and OMICS Group Conferences. OMICS Group hosts over 350 leading-edge peer reviewed Open Access Journals which are supported by more than 30000 eminent Editorial Board Members through a 21 Days rapid, quality and quick review process. The enhanced feature of the websites includes the language translations into French, Chinese, and Spanish. OMICS Publishing Group journals have over 3.5 million readers and organize over 100 International Conferences annually all over the world with the support of more than 150 scientific associations. OMICS Group Conferences conducts Scientific Conferences, symposia, workshops, trade shows, exhibitions and world congresses by bringing together people on a single platform thereby achieving and enlightening the knowledge across the world.

OMICS Group Conferences invites all the participants across the globe to attend the 3rd International Conference and Exhibition on Biowaivers and Biosimilars during October 27-29, 2014 Hyderabad, India. The main theme of the conference is "Current Challenges and Opportunities in Cost Effective and Affordable Biosimilars" which covers a wide range of critically important sessions. Biowaivers & Biosimilars International Conference 2014 is the best platform for Pharma, CMOs, CROs, research institutes, investors and industry stakeholders to meet, associate and discuss current industry trends and establish business partnerships. The target audience will be Vice Presidents, Directors, Heads of Departments in the field of Intellectual Property, Business Development, Bioequivalence, Regulatory/Legal Affairs, Research and Development and pharmacovigilance. Biowaivers & Biosimilars International Conference 2014 will gather the experts in the biosimilar development, manufacturing and commercialization decision makers from all over the world. Biosimilars-2014 is collaborated with DPA (Doctor of Pharmacy Association) and PAAi (Patent Agent Association). Workshop is being organized by Dr. Shivraj Dasari, CSO of SLS Cell Culture Technologies Pvt. Ltd at this esteemed scientific conference and this event will boost your industry knowledge and enhance relationships by networking between industrialists and academic leaders. Bio waivers & Biosimilars International Conference 2013 was supported by BioPort Folio (USA), ChemLinked (China) & Lab Bulletin (USA) and our Event exhibitor: FeF Chemicals, Denmark.   

Conference Highlights

  • Challenges and Regulatory Approach for Biosimilars
  • Emerging Biosimilars in Therapeutics
  • Clinical Studies and Clinicians Prospects for Biosimilars
  • Globalization of Biosimilars
  • Biosimilars Innovator Pharmaceutical Products
  • Analytical Strategies
  • Bioequivalence Assessment
  • BCS and IVIVC Based Biowaivers
  • Plant Produced Biosimilar Products
  • Pharmacovigilance and its Challenges

Biosimilars International Conference-2014 provides an in-depth discussion of key industry issues essential to biosimilars including cost effectual development and progression of methods, operation of clinical trials, appraising safety and quality, key strategies for dissolution testing, overcoming regulatory and legal issues and achieving access to emerging markets and commercialising biosimilars. The conference also covers the chief advancements of biowaivers. The world biosimilar monoclonal antibody (mAbs) market will produce $3,229m in 2018. Pharmaceutical Conferences Asia organized by OMICS Group Scientific Conferences includes the exhibitions, symposium, workshops. OMICS Group Conferences also organizes the poster competitions and young researcher forum in Biowaivers & Biosimilars International Conference 2014 to encourage the budding scientists and graduate students. OMICS group aims to inspire and share the ideas of the entrepreneurs to proceed more rapidly for further research in Biosimilars and related sessions like Emerging therapeutics in Biosimilars and Bioequivalence assessment. Biowaivers & Biosimilars International Conference 2014 encourage and explore the thesis of research study in the field of Biosimilars and BABE studies. 

Mark your calendars now and be part of this biosimilars conference going to be organized in India, to associate; exchange ideas and expand knowledge as we discover the future opportunities of Biosimilars in 2014!
Special Issues
All accepted abstracts will be published in respective OMICS Group Journals.
Abstracts will be provided with Digital Object Identifier by Cross Ref.
Conference Secretariat:
OMICS Group Conferences: 5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
Tel: 1-650-268-9744 Fax: 1-650-618-1414 Toll free: 1-800-216-6499 (USA & Canada), 1-800-651-097 (Australia)
Operated by Editors of: Journal of Bioanalysis & Biomedicine  |  Journal of Bioequivalence & Bioavailability